Liraglutide as an Additional Treatment to Insulin in Patients with Type 1 Diabetes Mellitus—A 52-Week Randomized Double-Blinded Placebo-Controlled Clinical Trial
用户sGjaISN0bR0M
1个月前
90
10
已关闭
DOI: https://doi.org/10.2337/db18-3-LB
其他信息:
出版社: American Diabetes Association
作者: PARESH DANDONA; HUSAM GHANIM; NITESH D. KUHADIYA; TANVI SHAH; JEANNE M. HEJNA; ANTOINE MAKDISSI; MANAV BATRA; AJAY CHAUDHURI
全文下载地址: https://diabetesjournals.org/diabetes/article/67/Supplement_1/3-LB/57050/Liraglutide-as-an-Additional-Treatment-to-Insulin

